FindTrial
Sign In

The effect of "UCB1577571 and CA050_01953" in the transplant model of psoriasis.

The effect of "UCB1577571 and CA050_01953" in the transplant model of psoriasis. - Transplant model of psoriasis

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON43021
Enrollment
18
Registered
2016-05-03
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

psoriasis

Interventions

None listed

Sponsors

Derphartox
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients with moderate to severe psoriasis

Exclusion criteria

Exclusion criteria: Volunteers undergoing UV/light therapy or taking systemic drugs such as cyclosporin A or methotrexate Volunteers using local topical corticosteroids Volunteers developing psoriasis at wound sites (Köbner phenomenon)

Design outcomes

Primary

MeasureTime frame
Effect on typical psoriasis skin features after treatment with "UCB1577571 en CA050_01953".—

Secondary

MeasureTime frame
-—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)